Prostate-specific Antigen as Surrogate for Characterizing Prostate Cancer Subgroups

By Sandblom G.   Holmberg L.   Damber J.-E.   Hugosson J.   Johansson J.-E.   Lundgren R.   Mattsson E.   Nilsson J.   Varenhorst E.  

Scandinavian Journal of Urology and Nephrology, Vol. 36, Iss. 2, 2002-04 ,pp. : 106-112

Informa Healthcare

Access to resources Recommend Favorite

Captopril may reduce biochemical (prostate-specific antigen) failure following radical prostatectomy for clinically localized prostate cancer

By Ronquist Gunnar   Frithz Goran   Wang Yu-Hui   Lindeborg Torsten  

Scandinavian Journal of Urology and Nephrology, Vol. 43, Iss. 1, 2009-02 ,pp. : 32-36

Informa Healthcare

Access to resources Recommend Favorite

Radiation therapy for T1 and T2 prostate cancer: prostate-specific antigen and disease outcome

By Zagars G.K.   Pollack A.  

Urology, Vol. 45, Iss. 3, 1995-03 ,pp. : 476-483

Elsevier

Access to resources Recommend Favorite

An analysis of the time course of postoperative prostate-specific antigen failure in patients with positive surgical margins: implications on the use of adjuvant therapy

By D'amico A.V.   Whittington R.   Malkowicz S.B.   Loughlin K.   Schultz D.   Schnall M.   Tempany C.M.   Tomaszewski J.E.   Renshaw A.   Wein A.  

Urology, Vol. 47, Iss. 4, 1996-04 ,pp. : 538-547

Elsevier

Access to resources Recommend Favorite

Impact of prostate-specific antigen screening on prostate cancer

By Zincke H.  

Urology, Vol. 47, Iss. 5, 1996-05 ,pp. : 783-783

Elsevier

Access to resources Recommend Favorite